ASX-Dividend-Report-Banner

Cyient Partners with MassMedic to Accelerate MedTech Innovation

March 05, 2024 01:00 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Cyient Partners with MassMedic to Accelerate MedTech Innovation
Image source: Kalkine Media

HYDERABAD, India, March 4, 2024 /PRNewswire/ -- Cyient, a global Intelligent Engineering and Technology Solutions company, is thrilled to announce its membership with the Massachusetts Medical Device Industry Council (MassMedic), the largest regional MedTech association in the United States. This partnership signifies a strategic move by Cyient to deepen its commitment to the healthcare sector, leveraging its extensive expertise in engineering and digital technologies to drive forward MedTech innovation.

Through this collaboration, Cyient aims to support the MedTech community by enhancing product development, testing, and compliance with regulatory standards. Cyient's proven track record in delivering end-to-end solutions will empower MedTech companies to navigate the complexities of the healthcare market more efficiently.

"Joining MassMedic marks a significant milestone in our journey toward becoming a key enabler in the MedTech industry," said Anand Parameswaran, President and Business Head – Healthcare & Life Sciences, Cyient. "Our goal is to leverage our deep domain knowledge and digital expertise to accelerate innovation, improve patient outcomes, and reduce healthcare costs."

As part of the partnership, Cyient and MassMedic will launch a series of initiatives aimed at addressing critical challenges in the MedTech sector. These will include collaborative workshops, thought leadership sessions, and innovation-driven projects designed to foster technological advancements and encourage knowledge sharing among industry leaders.

Rachel Robinson, COO of MassMedic, welcomed Cyient's membership, stating, "Cyient's engineering excellence and commitment to innovation make them a valuable addition to our association. Together, we look forward to driving significant advancements in the MedTech space."

This partnership is expected to yield substantial benefits for the MedTech community, enhancing the development and deployment of cutting-edge medical technologies that can lead to better health outcomes worldwide.

About Cyient:

Cyient (Estd: 1991, NSE: CYIENT) partners with over 300 customers, including 40% of the top 100 global innovators, to deliver intelligent engineering and technology solutions for a digital, autonomous, and sustainable future. As a company, Cyient is committed to Designing a culturally inclusive, socially responsible, and environmentally sustainable Tomorrow Together with our stakeholders.

For more information, please visit www.cyient.com.
Follow news about the company at @Cyient.

About MassMedic

The Massachusetts Medical Device Industry Council, an organization of 330 manufacturers, suppliers, research institutions, and academic health centers, promotes the unique interests of the Bay State's growing and vibrant medical device sector. Through a variety of programs, informational seminars, advocacy campaigns and other projects, MassMedic provides medical device manufacturers and suppliers with information on industry trends and regulatory policies, and creates forums that allow members to exchange ideas and information on issues affecting the industry.

For more information on MassMedic, please contact (617) 414-1340, or visit the website at www.massmedic.com.

For further information please contact:

Gowtham Uyalla

Kaizzen PR

+91 99892 22959

[email protected]

Phalguna Hari Jandhyala

Cyient  

[email protected]

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.